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This study evaluated the acute and sub-chronic toxicities of ethanol leaf extract of Dryopteris filix-mas. 
Acute toxicity and phytochemical tests on ethanol leaf extract were determined. In sub-chronic toxicity 
test, animals were treated with 62.5, 125, 250 and 500 mg/kg of extract every day for 90 days. Blood 
samples were collected via retro-orbital puncture for baseline studies and at 31, 61 and 91st days for 
determination of hematological, kidney and liver function parameters. Liver and kidneys were harvested 
for histopathology analyses on 91st day. Also, a 28 day recovery study was carried out to determine 
reversibility in toxicological effects. Phytochemical screening revealed the presence of tannins, phenols, 
flavonoids, saponins, steroids, alkaloids, terpenoids, reducing sugar and cardiac glycosides. Acute toxicity 
test did not show toxicity or death at 5000 mg/kg. There was significant (p<0.005) reduction in white 
blood cell and lymphocyte counts, significant (p<0.05) increase in some liver and kidney biomarkers as 
well as alterations in liver and kidney histo-architecture on 91st days in animals that were treated with 
250 and 500 mg/kg extract. However, toxicities observed on 91st day were reversible in recovery studies. 
The leaf extract of Dryopteris filix-mas may be hepatotoxic and nephrotoxic when used for long periods.
Keywords: Dryopteris filix mas Leaf Extract. Sub-chronic toxicity. Acute toxicity. Nephrotoxicity. 
Hepatotoxicity. Dryopteris/toxicity. Toxicity tests/utilization. Ethanol/ toxicity.
INTRODUCTION
Medicinal plants are the richest alternative bio-
resources to synthetic drugs (Obi et al., 2012). Presently, 
there is a revitalization of interest in the use of medicinal 
plants by over 80% of the world population (Ogbonnia et 
al., 2011). In African countries, a large proportion of the 
population depends solely on herbal medicines for their 
primary health care needs. This is because medicinal 
plants are accessible, acceptable and affordable among 
the populace when compared to synthetic drugs (Obi et 
al., 2012). 
Dryopteris filix-mas, Dryoperidaceae is a deciduous 
evergreen perennial herb growing up to 60 -150 cm tall, 
with rhizomes. It is an effective ground cover plant that 
is native to Europe, Asia, and North America. It has a 
large light-green triangular frond (Sekendar et al., 2012). 
It is commonly found in streams, shady places and 
wetland areas. It is commonly referred to as male fern, 
Aspidium, water loving fern, worm fern and shield fern 
(Uwumarongie, Enike, Bafor, 2016). Its vernacular names 
include; fougère mâle (local French), sarkhas; shurud 
(Arabic), Eraketa (Urhobo), and Akpaka or Akolor (Igbo). 
The edible parts of Dryopteris filix-mas include; the leaves 
and root. The rhizomes can be eaten raw or cooked as part 
of a regimen for losing weight. In traditional medicine, the 
leaves and rhizome are used in the treatment of rheumatoid 
arthritis, inflammation, malaria, worm infestation, internal 
haemorrhage, uterine bleeding, fever, mumps, carbuncles 
and sores (Sekendar et al., 2012). The leaves, roots and 
rhizomes are used to rinse hair and to treat dandruffs 
(Sekendar et al., 2012; Soare et al., 2012). Literature 
had reported its anti-diarrheal activity (Uwumarongie, 
Enike, Bafor, 2016), antioxidant and cytotoxic activities 
(Sekendar et al., 2012), anti-helmintic activity (Urban et 
al., 2014) and anti-microbial activity (Soare et al., 2012).
Following the ethnomedicinal values of Dryopteris 
filix-mas in Nigeria, there are no scientific literatures to 
validate its safety profile due to its repeated use overtime 
in the treatment and management of various diseases. The iD
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main purpose of this study is to evaluate the sub-chronic 
toxicities of Dryopteris filix-mas leaf extract on some 
toxicological parameters.
MATERIAL AND METHODS
Material
Equipments and apparatuses used in this study 
include; visible Spectrophotometer (721G, Zhejiang 
Top Cloud-Agri Technology Co., Ltd., China), Abacus 
Junior hematology Analyzer (Diatron Abacus 380, 
Hungary), table Centrifuge, thermostatic water bath 
(Equitron Mumbai India), analytical weighing balance 
(Ohaus Corp. Pine Brook, NJ USA), animal cages and 
micro pipettes.
Chemicals and reagents
Chemicals and reagents used in this study include 
sodium hydroxide pellets (Avondale Laboratories supplies 
and Services, England), Ethanol (JHD, Guangdong 
Guanghua Schi-Tech), Formaldehyde (May and Baker 
Ltd, Dagenham England). Aspartate aminotransferase 
(AST), Alanine aminotransferase (ALT), Triglyceride, 
Total cholesterol, High density lipoprotein cholesterol 
(HDL-c) reagent kits were procured from Randox 
Laboratories Limited, Country Atrium, United Kingdom 
while Sodium, Chloride, Potassium, Urea, Creatinine, 
Total protein, Albumin and Alkaline phosphatase (ALP) 
kits were procured from Teco diagnostics, California 
U.S.A.
Experimental animals
Albino rats of either sex were procured from 
Department of Veterinary Medicine, University of 
Nigeria Nnsukka. They were kept in the animal house, 
Department of Pharmacology and Toxicology, Faculty of 
Pharmaceutical Sciences, Nnamdi Azikiwe University, 
Agulu and were given access to water and pelletized 
vital grower feed ad libitum under 12:12 hours light and 
dark cycle. Animals were handled in conformity with the 
National Institute of Health Guidelines for the care and 
use of laboratory animals for research purpose (Pub No. 
85-23, revised 1985).
Plant collection and authentication
Fresh leaves of Dryopteris filix-mas were collected 
between 6:30 and 8:00 am in the month of March, 2016 
from a swampy area beside the Horticulture botanical 
garden, Amawbia, Awka South L.G.A, Anambra State, 
Nigeria. Plant specimen was validated by Dr. Akinnibosun 
H.A, a plant taxonomist of the Department of Plant 
Biology and Biotechnology, Faculty of Life Sciences, 
University of Benin, Benin City, Nigeria. It was deposited 
in the herbarium of the Department and Voucher number 
“UBHd285A” was assigned to it.
Preparation of plant extract
The extract was prepared using maceration method 
described by Azubike et al. (2015). Fresh leaves of 
Dryopteris filix-mas were washed with tap water and air-
dried at room temperature for one week. Crisply dried 
leaves were pulverized using mechanical grinder and a 
total of 4.7 kg was extract by cold-macerated using 80 % 
aqueous ethanol for a period of 48 hour, with occasional 
agitation. Filtrate was recovered with the aid of a muslin 
clothe. Final filtrate recovered was concentrated using 
water bath at 40 °C until a greenish paste was formed.
Phytochemical screening
The extract was screened for the presence of 
proteins, reducing sugars, tannins, flavonoids, saponins, 
cardiac glycosides, steroids, terpenoids, anthraquinolones 
and alkaloids using methods of Sofowora (1993), Trease, 
Evans (1989) and Harborne (1973).
Acute toxicity test
Acute toxicity test on the extract was carried out in 
rats using the method of Miller and Tainter as described 
by Randhawa (2009). Sixty 60 albino rats (129.86 ± 0.98 g 
body weight) of either sex were grouped into 6 groups of 
10 animals each as follows; control, 100, 1000, 2000, 3000 
and 5000 mg/kg of extract. The control group was given 
10 mL/kg of distilled water. Observation was made during 
the first 4 hours and after 24 hours for signs of toxicity or 
death. Also, 2 weeks observation was given to the animals 
for signs of delayed toxicity and death.
Sub-chronic toxicological studies
The protocol described by Ilodigwe, Akah, Nworu 
(2010) was used in this study with some modifications. A 
total of sixty (60) albino rats of either sex (84.00 ± 2.89 g 
body weight) were randomized into five groups of twelve 
animals each as follows: Control group (10 mL/kg, 
distilled water), and test groups (62.5, 125, 250 and 500 
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mg/kg of the extract). The extract was reconstituted in 
distilled water to form various concentrations, 50 mg/mL, 
25 mg/mL, 12.5 mg/mL and 6.25 mg/mL for 500, 250, 
125 and 62.5mg/kg respectively. Blood samples were 
collected via the retro-orbital plexus for determination of 
baseline hematological parameters using Abacus Junior 
Hematology Analyzer (Diatron Abacus 380). Serum 
recovered from blood samples collected into plain tube and 
centrifuged at 3500 rpm for 10 minutes was diluted 5-fold 
with normal saline and used for the assay of biochemical 
parameters including alkaline phosphatase (ALP), alanine 
aminotransferases (ALT), aspartate transaminases (AST), 
total protein, albumin, sodium, potassium, chloride, 
calcium, urea, creatinine, total cholesterol, triglyceride and 
high density lipoprotein cholesterol using manufacturers’ 
(Randox and Teco) kits leaflets procedures with little 
modifications. Normal saline was added to reagent blank 
and the resulting absorbance of sample was multiplied 
by five. After baseline assessment, animals were dosed 
daily with the extract for a period of 90-days. On 31st, 
61st and 91st days, blood samples collected from retro-
orbital plexus into EDTA tubes and plain tubes were 
used for determination of hematological and biochemical 
parameters respectively using similar protocols described 
for baseline studies. Body weight gain and organ weights 
were recorded. Liver and kidney were fixed in 10 % formal 
saline for histopathological analyses using the method 
described by Bancroft, Gamble (2002). Photomicrographs 
were captured and interpreted by a histopathologist at 
× 400 magnifications using Microscope attached to a 
digital camera. Animals’ stomachs were removed and cut 
open along the lesser curvature and washed with tap water 
and observed for presence or absence of lesions using the 
method described by Moke, Ilodigwe, Erhirhie (2015).
Recovery studies
At the end of 90-days, animals were placed on feed 
and water ad-libitum without extract administration for 
28-days. At the end of 28 days (day 29th), blood samples 
collected from retro-orbital plexus of animals were used 
for the determination of hematological and biochemical 
parameters. Body weights and organ weights were 
recorded. Liver and kidney were fixed in 10% formal 
saline for histopathological analyses.
Method of data analyses
Results were presented as mean ± Standard error of 
mean (SEM) of sample replicates (n=5). Raw data were 
analyzed using one way analyses of variance (ANOVA), 
followed by post hoc Turkey’s test using Statistical 
Package for Social Science (SPSS, version 20). p<0.05 
was established to be statistically significant.
RESULTS AND DISCUSSION
This study evaluated the sub-chronic toxicity profile 
of Dryopteris filix-mas in albino rats. From LD50 study, 
there were no signs of toxicity or death recorded at various 
doses (100, 1000, 2000, 3000 and 5000 mg/kg) of the 
extract after 24 hours and subsequently for 14-days when 
compared to control group. This suggests that the extract 
is not toxic on short term exposure in this experimental 
condition. LD50 value above 5000 mg/kg is classified 
as non-toxic (Muhammad et al., 2015). Phytochemical 
screening revealed the presence of tannins, flavonoids, 
saponins, steroids, alkaloids, terpenoids and reducing 
sugars in the leaf extract of Dryopteris filix-mas (Table I). 
These secondary metabolites have been shown to exert 
various toxicological effects apart from their benefits 
(Aksel, 2010; Yadav, Agarwala, 2011). In support of this 
finding, Uwumarongie and co-workers in the study of 
the phytochemical constituents of Dryopteris filix mas 
leaf also reported the presence of glycosides, tannins, 
flavonoids, steroids and other nutrients (Uwumarongie, 
Enike, Bafor, 2016).
Hematological parameters assessment is vital 
among various toxicity biomarkers to know whether test 
substances affect the hematopoitic system (Bashir et al., 
2015). From Table II, there was significant (*p<0.05) 
increase in PCV, RBC and hemoglobin on 31st day 
following the administration of 250 and 500 mg/kg 
of Dryopteris filix-mas leaf extract to albino rats. This 
suggests that Dryopteris filix-mas could promote red 
TABLE I - Qualitative phytochemistry results
Phytochemicals Results
Tannins ++
Flavonoids +++
Saponins ++
Steroids ++
Alkaloids ++
Terpenoids ++
Anthraquinolones -
Cardiac glycosides +
Reducing sugars +
 “-”:absent, “+” :trace “++” : moderate and “+++”: abundant. 
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blood cell production at 250 and 500 mg/kg doses after 
30 days of its exposure to animals. Plant secondary 
metabolites such as flavonoids and terpenoids have been 
reported to promote erythropoisis (Osano et al., 2016) 
and presence of these metabolites in the extract (Table I) 
may account for increase in PCV, RBC and hemoglobin 
on day 31st. Non-significant changes in PCV, hemoglobin 
and RBC levels on 61 and 91st days suggest that the extract 
does not promote red blood cell production at 250 and 
500 mg/kg after longer duration of exposure. Long term 
intake of medicinal plants rich in saponins had been 
reported to cause hemolysis of red blood cells (Ekpenyong, 
Akpan, Udoh, 2012). Study by Kumar, Karthik, Rao 
(2011) also revealed that presence of saponins in extracts 
of some Indian medicinal plants resulted in hemolytic 
effects due to alteration in the erythrocyte membrane. 
Thus, presence of saponins in the extract may account for 
the reversibility in high PCV, RBC and hemoglobin levels 
of 31st day on 61 and 91st days.
From Table III, there was significant (*p<0.05) 
decrease in WBC and lymphocyte counts and significant 
(*p<0.05) increase in granulocyte and medium size cells 
TABLE II - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on packed cell volume (PCV), red blood 
cell (RBC), hemoglobin and platelet (PLAT) levels of albino rats
Treatment PCV (%) RBC (106/µL) Hemoglobin (g/dL) PLAT (103/µL)
Baseline
Control 45.66 ± 1.00 7.49 ± 1.54 14.66 ± 0.29 864.40 ± 41.48
61.25 mg/kg 43.03 ± 1.61 7.24 ± 0.22 15.14 ± 0.51 847.80 ± 37.47
125 mg/kg 44.78 ± 0.74 7.18 ± 0.16 15.46 ± 0.49 832.20 ± 39.55
250 mg/kg 44.46 ± 1.50 7.51 ± 0.16 14.58 ± 0.41 795.60 ± 46.06
500 mg/kg 42.56 ± 0.93 7.35 ± 0.20 15.46 ± 0.27 847.40 ± 32.45
Day 31st 
Control 41.03 ± 1.33 6.24 ± 0.30 14.74 ± 0.57 677.80 ± 54.22
61.25 mg/kg 39.97 ± 1.68 6.58 ± 0.25 14.05 ± 0.70 677.80 ± 48.59
125 mg/kg 39.77 ± 0.96 6.34 ± 0.28 13.86 ± 0.28 618.60 ± 37.94
250 mg/kg 54.56 ± 3.61* 8.39 ± 0.12* 19.55 ± 1.31* 664.00 ± 43.81
500 mg/kg 54.34 ± 4.81* 8.55 ± 0.19* 19.34 ± 1.79* 786.60 ± 86.02
Day 61st 
Control 41.18 ± 0.67 6.63 ± 0.14 14.20 ± 0.21 675.20 ± 77.68
61.25 mg/kg 40.44 ± 0.65 6.63 ± 0.15 13.88 ± 0.16 667.40 ± 66.13
125 mg/kg 40.28 ± 1.50 6.52 ± 0.27 14.02 ± 0.54 633.40 ± 29.53
250 mg/kg 41.14 ± 1.13 6.70 ± 0.15 14.54 ± 0.41 561.00 ± 25.80
500 mg/kg 40.77 ± 0.56 6.64 ± 0.14 13.86 ± 0.16 599.20 ± 27.20
Day 91st 
Control 42.74 ± 1.01 7.00 ± 0.22 13.68 ± 0.35 760.80 ± 42.92
61.25 mg/kg 42.47 ± 0.45 6.77 ± 0.37 13.99 ± 0.12 681.20 ± 23.22
125 mg/kg 43.71 ± 0.38 6.89 ± 0.07 14.06 ± 0.17 821.00 ± 54.83
250 mg/kg 42.19 ± 1.06 6.96 ± 0.16 13.12 ± 0.35 780.40 ± 30.97
500 mg/kg 44.26 ± 1.83 7.15 ± 0.32 13.62 ± 0.60 837.40 ± 37.43
Recovery
Control 43.48 ± 1.18 6.94 ± 0.29 13.12 ± 0.39 797.80 ± 68.75
61.25 mg/kg 43.28 ± 0.94 6.95 ± 0.21 13.38 ± 0.36 793.20 ± 47.88
125 mg/kg 44.65 ± 1.36 7.11 ± 0.29 13.66 ± 0.46 707.80 ± 82.30
250 mg/kg 42.59 ± 0.82 6.72 ± 0.23 12.92 ± 0.34 734.60 ± 70.48
500 mg/kg 44.89 ± 0.89 7.04 ± 0.11 13.73 ± 0.19 835.40 ± 33.18
Values are presented as mean ± Standard error of mean (n =5). *p<0.05: Statistically significantly different from control group.
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count on 91st day following the administration of 250 and 
500 mg/kg of Dryopteris filix-mas leaf extract to albino 
rats. This suggests that bioaccumulation of the extract 
due to its 90 days exposure to animals could disrupt bone 
marrow function resulting to insufficient production of 
leukocytes. Debelo et al. (2016) stated that reduction 
in WBC level is associated with immune suppression. 
Studies by Unakalamba, Ozougwu, Ejere (2013) revealed 
that saponins in medicinal plants could cause decrease 
production in WBC. Usually, reduction in total leukocyte 
and lymphocyte count correlates with increase in MID and 
granulocyte count (Yadav et al., 2010). Non significant 
change in these parameters following 28 days recovery 
studies suggests that leukocyte suppression effect of the 
extract was reversible.
From Table IV, there was no significant difference 
(p>0.05) in PCT, MPV, MCV, MCH, and MCHC levels 
on 31, 61 and 91st days in animals treated with various 
doses (62.5, 125, 250 and 500 mg/kg) of Dryopteris 
filix-mas leaf extract. This indicates that components of 
these blood parameters may not be deleteriously affected 
by the extract. 
TABLE III - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on white blood cell (WBC), lymphocyte 
(Lymp), granulocyte (Gran), and medium size cell counts (MID) of albino rats
Treatment WBC (103/µL) Lymp (%) Gran (%) MID (%)
Baseline
Control 6.53 ± 0.32 62.92 ± 0.99 24.81 ± 0.81 12.27 ± 0.51
61.25 mg/kg 6.60 ± 0.45 62.85 ± 1.10 25.33 ± 1.31 11.82 ± 0.60
125 mg/kg 6.37 ± 0.30 62.65 ± 0.51 24.70 ± 0.45 12.65 ± 0.20
250 mg/kg 5.94 ± 0.13 62.85 ± 0.73 25.15 ± 0.47 12.00 ± 0.36
500 mg/kg 6.52 ± 0.24 62.80 ± 0.40 24.50 ± 0.34 12.70 ± 0.24
Day 31st 
Control 7.25 ± 0.88 76.04 ± 5.74 20.52 ± 2.16 9.18 ± 0.92
61.25 mg/kg 6.86 ± 0.68 71.38 ± 5.72 19.86 ± 1.32 8.98 ± 0.66
125 mg/kg 5.82 ± 0.36 71.24 ± 1.54 17.86 ± 2.35 9.90 ± 0.44
250 mg/kg 6.58 ± 0.49 73.52 ± 3.19 18.56 ± 1.78 11.96 ± 1.96
500 mg/kg 6.52± 0.88 71.70 ± 4.94 17.66 ± 1.93 13.30 ± 4.26
Day 61st 
Control 6.84 ± 1.16 69.54 ± 3.56 18.60 ± 2.44 11.86 ± 1.58
61.25 mg/kg 6.17 ± 1.11 70.02 ± 0.21 19.47 ± 0.75 10.51 ± 0.59
125 mg/kg 5.91 ± 0.51 69.82 ± 1.38 19.56 ± 1.17 10.62 ± 0.76
250 mg/kg 5.57 ± 0.79 69.00 ± 3.34 20.10 ± 2.96 10.90 ± 0.58
500 mg/kg 4.49 ± 0.37 66.88 ± 1.07 21.76 ± 1.01 11.36 ± 0.69
Day 91st 
Control 6.09 ± 0.50 72.44 ± 0.88 15.92 ± 0.37 11.50 ± 0.87
61.25 mg/kg 5.94 ± 0.98 73.00 ± 1.11 15.82 ± 0.96 11.18 ± 0.55
125 mg/kg 6.53 ± 0.62 71.22 ± 1.22 16.38 ± 1.24 12.40 ± 1.04
250 mg/kg 4.46 ± 0.43* 61.88 ± 0.73* 22.22 ± 0.69* 15.90 ± 0.34*
500 mg/kg 3.48 ± 0.15* 56.18 ± 1.37* 25.92 ± 1.30* 17.90 ± 0.76*
Recovery
Control 5.75 ± 0.75 69.80 ± 1.28 17.22 ± 0.77 13.00 ± 0.63
61.25 mg/kg 5.85 ± 0.65 70.40 ± 0.77 16.62 ± 0.68 12.98 ± 0.17
125 mg/kg 6.60 ± 0.54 68.60 ± 0.76 17.04 ± 0.29 14.36 ± 0.53
250 mg/kg 5.76 ± 0.50 67.86 ± 0.95 17.95 ± 0.51 14.18 ± 0.66
500 mg/kg 5.25 ± 0.78 68.42 ±0.30 17.12 ± 0.82 14.46 ± 0.68
Values are presented as mean ± Standard error of mean (n = 5). *p<0.05: Statistically significantly different from control group.
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Increase in cholesterol and triglyceride levels could 
be associated with cardiovascular and coronary heart 
disease (Kayode et al., 2016). From this study, significant 
reduction in total cholesterol and triglyceride levels at 
250 mg/kg dose on day 61 (Table V) suggests that 250 
mg/kg dose could promote lipid lowering. Presence of 
saponins and flavonoids in medicinal plants have been 
reported to play significant roles in cholesterol and lipid 
lowering (Yadav, Agarwala, 2011; Builders, Isichie, 
Aguiyi, 2012).
Liver enzymes (AST, ALT, ALP), total protein and 
albumin concentrations are considered when assessing 
liver function. Therefore, alteration in the level of these 
biomarkers could be an indication of liver injury. When 
the liver is exposed to toxicants, damage to its membrane 
may occur, thereby causing leakages and elevation in the 
level of these enzymes in the blood circulation. On the 
other hand, whenever the liver is protected, its membrane 
remains intact thereby causing non-alteration or reduction 
in its enzyme levels (Otunola, Afolayan, 2017).
From Table VI, significant increase in liver enzymes 
(ALT, AST and ALP) in 250 and 500 mg/kg groups on 91st 
TABLE IV - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on platelet percentage (PCT), mean 
platelet volume (MPV), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin 
concentration (MCHC) of albino rats
Treatment PCT (%) MPV (fL) MCV (fL) MCH (pg) MCHC (g/dL)
Baseline
Control 0.97 ± 0.04 8.94 ± 0.17 65.00 ± 0.45 21.04 ± 0.17 32.14 ± 0.52
61.25 mg/kg 0.88 ± 0.04 8.76 ± 0.09 64.80 ± 0.97 20.74 ± 0.37 32.72 ± 0.67
125 mg/kg 0.83 ± 0.02 8.66 ± 0.26 64.40 ± 0.87 20.94 ± 0.39 32.62 ± 0.63
250 mg/kg 0.81 ± 0.06 8.70 ± 0.61 63.60 ± 0.68 20.36 ± 0.57 32.74 ± 0.45
500 mg/kg 0.95 ± 0.05 8.48 ± 0.25 65.00 ± 0.63 20.50 ± 0.29 33.54 ± 0.32
Day 31st 
Control 0.52 ± 0.04 7.72 ± 0.24 63.20 ± 1.02 20.84 ± 0.35 33.12 ± 0.28
61.25 mg/kg 0.53 ± 0.05 7.60 ± 0.2 63.4 ± 1.28 20.84 ± 0.53 32.56 ± 0.87
125 mg/kg 0.47 ± 0.02 7.56 ± 0.14 62.60 ± 1.08 20.12 ± 0.35 32.16 ± 0.24
250 mg/kg 0.54 ± 0.03 8.16 ± 0.17 66.40 ± 2.42 21.54 ± 0.52 32.42 ± 0.47
500 mg/kg 0.62 ± 0.07 7.98 ± 0.21 63.40 ± 1.57 20.94 ± 0.69 33.10 ± 0.59
Day 61st 
Control 0.71 ± 0.07 7.74 ± 0.24 62.00 ± 0.71 21.46 ± 0.22 34.48 ± 0.14
61.25 mg/kg 0.68 ± 0.05 7.64 ± 0.30 63.40 ± 1.03 21.38 ± 0.42 33.62 ± 0.60
125 mg/kg 0.65 ± 0.02 7.30 ± 0.07 61.80 ± 1.02 21.50 ± 0.38 34.80 ± 0.24
250 mg/kg 0.63 ± 0.03 7.70 ± 0.18 61.40 ± 0.68 21.68 ± 0.58 35.30 ± 0.70
500 mg/kg 0.65 ± 0.02 7.64 ± 0.09 61.60 ± 1.72 20.94 ± 0.54 34.02 ± 0.14
Day 91st 
Control 0.60 ± 0.04 7.84 ± 0.09 61.20 ± 1.74 19.54 ± 0.21 32.02 ± 0.70
61.25 mg/kg 0.60 ± 0.05 7.48 ± 0.12 60.8 ± 1.31 19.37 ± 0.28 32.01 ± 0.83
125 mg/kg 0.65 ± 0.05 7.94 ± 0.14 63.50 ± 0.50 20.42 ± 0.19 32.18 ± 0.16
250 mg/kg 0.66 ± 0.02 8.42 ± 0.29 60.60 ± 1.53 18.90 ± 0.39 31.12 ± 0.20
500 mg/kg 0.68 ± 0.04 8.16 ± 0.17 62.20 ± 1.02 19.08 ± 0.42 30.78 ± 0.32
Recovery
Control 0.63 ± 0.06 7.84 ± 0.08 60.20 ± 0.37 21.40 ± 0.25 32.25 ± 0.27
61.25 mg/kg 0.63 ± 0.04 7.84 ± 0.23 61.60 ± 0.51 20.20 ± 0.20 32.25 ± 0.34
125 mg/kg 0.58 ± 0.06 7.72 ± 0.14 62.80 ± 0.86 20.88 ± 0.35 32.18 ± 0.54
250 mg/kg 0.57 ± 0.06 7.82 ± 0.17 61.20 ± 0.86 20.32 ± 0.50 31.23 ± 0.44
500 mg/kg 0.66 ± 0.04 7.90 ± 0.31 63.60 ± 0.60 22.30 ± 1.03 32.38 ± 0.39
Values are presented as mean ± Standard error of mean (n =5). p>0.05: Not statistically significantly different from control group.
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day suggests that the extract could cause hepatic injury 
when used for long duration. These biochemical changes 
were corroborated by the liver histopathology results 
(Figure 1) characterized by congestion of the hepatic 
triad leading to displacement of red blood cells from the 
intravascular space to the loose connective tissues in dose 
dependent manner. In recovery studies, significant increase 
in liver enzymes, as well as histopathological changes 
observed on 91st day were not observed (Table VI and 
Figure 2), suggesting that the injuries attributed to long 
term exposure to the extract for 90 days was reversible. 
Electrolytes (sodium, potassium, chloride and 
calcium), urea and creatinine are put into consideration 
when assessing kidney function. Increase in renal 
biomarkers as well as alteration in kidney cytoarchitecture 
is an indication of compromised renal functions 
(Ogbonnaya, Uadia, 2016).
Non-significant change in electrolytes and total 
protein (Table VII) suggests that the physiological function 
of these biomarkers may not be hampered following the 
intake of the extract for 90 days.
However, significant increase in kidney function 
parameters, urea and creatinine (Table VIII) on the 91st 
day suggests that the extract could be associated with 
kidney injury due to its longer duration of exposure. These 
changes were corroborated by the kidney histopathology 
TABLE V - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on Lipid profile of albino rats
Treatment Total cholesterol (mg/dL)
Triglyceride 
(mg/dL)
HDL-cholesterol 
(mg/dL)
LDL-cholesterol 
(mg/dL)
Baseline
Control 148.17 ± 3.39 114.34 ± 2.51 51.85 ± 2.03 73.46 ± 3.05
61.25 mg/kg 149.27 ± 1.89 113.13 ± 3.53 52.92 ± 3.06 73.73 ± 4.38
125 mg/kg 141.52 ± 2.02 113.49 ± 2.55 49.39 ± 3.42 69.43 ± 3.42
250 mg/kg 146.00 ± 2.36 111.17 ± 2.81 50.68 ± 4.42 73.08 ± 3.88
500 mg/kg 146.93 ± 2.16 108.78 ± 2.79 52.55 ± 3.58 72.62 ± 4.71
Day 31st 
Control 142.02 ± 5.37 111.24 ± 3.05 57.18 ± 1.23 62.59 ± 5.78
61.25 mg/kg 130.82 ± 3.89 114.16 ± 2.79 57.65 ± 1.77 50.33 ± 5.23
125 mg/kg 141.03 ± 8.28 110.45 ± 2.60 59.91 ± 1.23 59.02 ± 8.06
250 mg/kg 132.13 ± 7.98 112.57 ± 4.83 60.63 ± 0.87 48.99 ± 7.04
500 mg/kg 135.43 ± 3.95 112.04 ± 1.36 60.99 ± 1.15 52.03 ± 4.82
Day 61st 
Control 140.71 ± 6.33 117.47 ± 4.52 66.67 ± 1.84 50.55 ± 7.63
61.25 mg/kg 115.47 ± 6.88 118.10 ± 3.40 71.59 ± 2.43 42.44 ± 5.72
125 mg/kg 125.41 ± 3.71 95.84 ± 7.75 74.62 ± 7.08 31.63 ± 9.10
250 mg/kg 115.47 ± 6.88* 81.22 ± 4.70* 68.56 ± 3.14 30.67 ± 5.98
500 mg/kg 126.18 ± 6.51 98.87 ± 5.57 75.00 ± 2.21 31.40 ± 5.32
Day 91st 
Control 141.86 ± 4.19 119.93 ± 5.66 62.53 ± 5.49 55.34 ± 3.94
61.25 mg/kg 146.20 ± 4.94 122.77 ± 2.43 61.61 ± 3.07 60.04 ± 7.80
125 mg/kg 144.03 ± 8.52 116.99 ±2.92 56.05 ± 2.55 64.58 ± 8.88
250 mg/kg 135.34 ± 3.25 123.68 ± 5.62 65.77 ± 4.34 44.83 ± 4.98
500 mg/kg 151.26 ± 9.46 111.32 ± 5.77 70.64 ± 3.53 58.36 ± 13.72
Recovery
Control 142.45 ± 1.83 129.01 ± 5.54 65.44 ± 1.61 51.21 ± 2.77
61.25 mg/kg 144.81 ± 3.05 132.83 ± 2.89 68.16 ± 1.56 50.09 ± 3.15
125 mg/kg 143.80 ± 1.62 133.24 ± 3.96 69.92 ± 0.62 47.22 ± 2.23
250 mg/kg 141.01 ± 2.06 123.06 ± 2.67 70.78 ± 0.80 45.62 ± 1.76
500 mg/kg 139.41 ± 2.11 123.09 ± 3.92 69.66 ± 1.41 45.12 ± 2.24
Values are presented as mean ± Standard error of mean (n =5). *p<0.05: Statistically significantly different from control group.
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result which is characterized by predominant glumeruli 
proliferation with loose Bowmans’ space in extensive 
areas of the kidney in dose dependent manner (Figure 3). 
Also, this suggests that doses below 250 mg/kg may 
be tolerated and safe even beyond 90 days exposure. 
Significant increase in kidney function parameters and 
kidney histopathological changes observed on the 91st 
day were not observed in the recovery studies (Table 
VIII and Figure 4), suggesting that the injuries attributed 
to long term exposure of the extract for 90 days was not 
permanent. 
Liver and kidney toxicities observed on 91st day 
of this study could be attributed to the effects of some 
secondary metabolites present in the extract of Dryopteris 
filix-mas as revealed in the phytochemistry result (Table I). 
Studies have revealed that exposure to high levels of 
plant secondary metabolites such as tannins, saponins, 
glycosides and alkaloids could cause hepatorenal toxicity 
(Netala et al., 2014; Louis et al., 2014; Mariangela 
et al., 2016). Report had also shown that long term 
consumption of medicinal plant rich in flavonoids could 
result to auto-oxidation of reactive oxygen species thereby 
causing liver and kidney toxicities (Namjoo et al., 2013). 
Long term intake of cardiac glycosides and diterpenoid 
glycosides had been reported to cause renal proximal 
tubule necrosis as well as centrilobular hepatic necrosis 
TABLE VI - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on Liver enzymes, alanine 
aminotransferase (ALT), aspertate aminotransferase (AST), alkaline phosphatase (ALP), total protein and albumin of albino rats 
Treatment ALT (U/L) AST (U/L) ALP (IU/L) Albumin (g/dL)
Baseline
Control 16.54 ± 0.67 38.83 ± 1.11 46.45 ± 1.81 3.26 ± 0.06
61.25 mg/kg 17.32 ± 0.57 35.05 ± 0.90 48.64 ± 1.88 3.27 ± 0.09
125 mg/kg 16.26 ± 0.50 37.45 ± 1.27 47.41 ± 1.98 3.26 ± 0.14
250 mg/kg 16.34 ± 0.55 37.06 ± 1.50 43.63 ± 0.35 3.15 ± 0.07
500 mg/kg 15.39 ± 0.66 36.92 ± 1.06 48.73 ± 1.70 3.26 ± 0.04
Day 31st 
Control 15.58 ± 0.86 38.47 ± 0.94 62.66 ± 7.71 3.43 ± 0.23
61.25 mg/kg 15.23 ± 0.85 36.33 ± 1.98 62.75 ± 7.40 3.47 ± 0.27
125 mg/kg 12.37 ± 1.21 32.52 ± 2.57 51.16 ± 4.30 3.80 ± 0.22
250 mg/kg 12.82 ± 1.15 34.76 ± 1.10 52.63 ± 6.65 3.92 ± 0.20
500 mg/kg 13.49 ± 1.59 35.56 ± 2.10 56.49 ± 10.32 3.54 ± 0.26
Day 61st 
Control 19.78 ± 0.65 37.72 ± 0.55 55.22 ± 0.51 3.69 ± 0.11
61.25 mg/kg 18.93 ± 0.42 37.94 ± 0.59 53.66 ± 6.11 3.72 ± 0.08
125 mg/kg 17.42 ± 1.85 37.67 ± 0.56 56.99 ± 3.35 3.60 ± 0.14
250 mg/kg 16.43 ± 1.60 37.93 ± 1.07 56.67 ± 3.44 3.88 ± 0.13
500 mg/kg 17.12 ± 1.36 37.62 ± 0.53 56.08 ± 0.91 3.67 ± 0.23
Day 91st 
Control 17.28 ± 0.93 35.00 ± 2.47 45.03 ± 3.82 3.94 ± 0.26
61.25 mg/kg 16.42 ± 0.58 39.13 ± 1.13 40.51 ± 1.25 4.45 ± 0.21
125 mg/kg 18.24 ± 1.72 40.60 ± 2.62 55.10 ± 1.00* 4.08 ± 0.20
250 mg/kg 23.36 ± 1.30* 59.50 ± 1.92* 63.70 ± 2.10* 3.82 ± 0.13
500 mg/kg 30.72 ± 1.28* 73.50 ± 2.21* 78.02 ± 3.05* 3.81 ± 0.28
Recovery
Control 15.92 ± 1.00 44.49 ± 1.09 42.30 ± 2.10 2.66 ± 0.17
61.25 mg/kg 16.16 ± 1.06 40.66 ± 1.55 41.34 ± 3.13 3.57 ± 0.26
125 mg/kg 14.18 ± 0.94 39.72 ± 1.68 43.25 ± 3.68 3.40 ± 0.23
250 mg/kg 14.30 ± 0.90 40.23 ± 0.83 37.64 ± 5.07 2.93 ± 0.11
500 mg/kg 13.26 ± 1.34 38.80 ± 1.86 42.23 ± 3.91 3.51 ± 0.26
Values are presented as mean ± Standard error of mean (n =5). *p<0.05: Statistically significantly different from control group. 
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biglobosa may be responsible for its liver and kidney 
damage. Osano et al. (2016) also revealed that saponins 
and tannins in methanol leaf extracts of Prosopis juliflora 
may be associated with its hepetorenal toxicity. From 
this study, presence of tannins, saponins, glycosides, 
flavonoids and alkaloids in Dryopteris filix-mas leaf 
in animals (Chikezie, Ibegbulem, Mbagwu, 2015). Nearly 
all alkaloids from plants are believed to be responsible for 
nitrogen secretion (like urea and uric acid in animals) and 
could be toxic when ingested in large quantity (Olivoto et 
al., 2017). Builders, Isichie, Aguiyi (2012) also revealed 
that presence of tannins in stem bark extract of Parkia 
FIGURE 1 - 91st day liver sections photomicrographs showing; Plate A (Control), Plate B (62.5 mg/kg), Plate C (125 mg/kg), 
Plate D (250 mg/kg), Plate E (500 mg/kg). H: Hepatocytes, BV: Blood vessel, S: Sinosoid. PTC: Portal triad congestion).
FIGURE 2 - Recovery liver sections photomicrographs showing; Plate A (Control), Plate B (62.5 mg/kg), Plate C (125 mg/kg), 
Plate D (250 mg/kg), Plate E (500 mg/kg). H: Hepatocytes disposed in sheet. S: sinusoids, BV: Blood vessel.
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TABLE VII - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on sodium, potassium, chloride and 
total protein of albino rats 
Treatment Sodium (mEq/L) Potassium (mEq/L)
Chloride 
(mEq/L)
Total protein 
(g/dL)
Baseline
Control 144.77 ± 2.68 4.47 ± 0.13 108.47 ± 2.13 4.23 ± 0.09
61.25 mg/kg 146.37 ± 5.63 4.28 ± 0.21 104.24 ± 1.53 4.61 ± 0.19
125 mg/kg 144.00 ± 2.75 4.49 ± 0.21 105.11 ± 3.04 4.64 ± 0.59
250 mg/kg 145.27 ± 6.78 4.55 ± 0.09 106.24 ± 2.72 4.24 ± 0.04
500 mg/kg 146.99 ± 3.46 4.39 ± 0.19 101.58 ± 3.65 4.27 ± 0.24
Day 31st 
Control 143.73 ± 0.69 4.08 ± 0.29 96.52 ± 2.75 4.94 ± 0.30
61.25 mg/kg 145.28 ± 1.66 3.95 ± 0.23 97.15 ± 3.70 4.93 ± 0.30
125 mg/kg 142.17 ±1.81 4.34 ± 0.22 92.22 ± 1.55 4.80 ± 0.15
250 mg/kg 142.42 ± 2.36 4.18 ± 0.23 86.88 ± 1.66 5.01 ± 0.16
500 mg/kg 139.96 ± 2.45 4.43 ± 0.20 90.95 ± 0.94 4.87 ± 0.08
Day 61st 
Control 131.17 ± 1.66 5.21 ± 0.14 95.99 ± 3.39 4.54 ± 0.26
61.25 mg/kg 130.96 ± 1.79 4.92 ± 0.31 93.60 ± 3.68 4.56 ± 0.20
125 mg/kg 133.42 ± 4.83 4.33 ± 0.76 88.72 ± 4.10 4.24 ± 0.19
250 mg/kg 141.63 ± 3.12 3.81 ± 0.04 96.23 ± 2.82 4.73 ± 0.41
500 mg/kg 141.26 ± 3.75 3.93 ± 0.53 100.20 ± 3.40 4.42 ± 0.29
Day 91st 
Control 132.01 ± 1.69 3.64 ± 0.22 93.26 ± 3.23 4.78 ± 0.34
61.25 mg/kg 134.13 ± 1.28 3.68 ± 0.14 94.72 ± 1.31 4.96 ±0.08
125 mg/kg 129.49 ± 0.35 4.35 ± 0.09 84.15 ± 3.52 5.01 ± 0.25
250 mg/kg 139.12 ± 6.68 3.14 ± 0.38 85.94 ± 4.76 5.13 ± 0.26
500 mg/kg 136.52 ± 1.12 4.03 ± 0.50 92.39 ± 2.68 5.26 ± 0.10
Recovery
Control 134.23 ± 3.83 3.96 ± 0.26 98.03 ± 9.67 4.06 ± 0.04
61.25 mg/kg 138.26 ± 5.11 3.42 ± 0.07 106.81 ± 4.88 4.11 ± 0.06
125 mg/kg 136.02 ± 3.80 4.28 ± 0.48 102.38 ± 3.85 4.08 ± 0.05
250 mg/kg 143.98 ± 1.75 5.15 ± 0.22 85.12 ± 6.37 4.01 ± 0.08
500 mg/kg 141.74 ± 3.31 3.93 ± 0.53 91.81 ± 3.88 4.10 ± 0.09
Values are presented as mean ± Standard error of mean (n =5). p>0.05: Not statistically significantly different from control group.
extract may be responsible for the liver and kidney 
toxicities observed on 91st day.
Non-significant difference (p>0.05) in body 
weight gain of animals treated with various doses of 
the extract for 90 days (Table IX) suggests that sub-
chronic administration of the extract does not contribute 
to body weight reduction. Ekpenyong, Akpan, Udoh 
(2012) reported that high level of hydrolysable tannins 
(non-digestable form) from phytochemicals could cause 
appetite suppression and body weight reduction when 
compared to condensed tannins. 
Non-significant changes in organs weights on 
91st day and in recovery studies (Tables X) indicate 
that the extract may not be associated with hypertrophy 
or hyperplasia. Studies by Otunola, Afolayan (2017) 
revealed that increase or decrease in organ weights may 
be associated with marked organ toxicity.
Studies by Moke, Ilodigwe, Erhirhie (2015) revealed 
that evaluation of ulcerogenic properties of medicinal 
plants could aid in validating their safety profile relating 
to long term use. Absence of ulcerations in the stomach 
mucosa of rats that were exposed to the extract for 90 days 
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(Table XI) suggest that the extract is not be ulcerogenic in 
the stomach mucosa on long term use.
CONCLUSIONS
Acute toxicity study revealed that ethanol leaf 
extract of Dryopteris filix-mas may be safe on single dose 
exposure. However, 90 days repeated exposure of animals 
to 250 and 500 mg/kg doses of this extract may cause 
reduction in leukocyte counts and hepatorenal injuries, 
which may be reversible.
Thus, caution should be exercised by consumers 
who use high doses of the extract over a long period of 
time.
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TABLE VIII - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on urea, creatinine and calcium of 
albino rats 
Treatment Urea (mg/dL) Creatinine (mg/dL) Calcium (mg/dL)
Baseline
Control 19.88 ± 0.86 4.36 ± 0.21 10.80 ± 0.62
61.25 mg/kg 20.82 ± 0.45 4.28 ± 0.16 8.93 ± 0.45
125 mg/kg 19.86 ± 0.62 3.95 ± 0.10 9.95 ± 0.46
250 mg/kg 21.15 ± 0.49 4.00 ± 0.17 10.51 ± 0.31
500 mg/kg 20.40 ± 0.59 4.19 ± 0.21 9.73 ± 0.48
Day 31st 
Control 19.65 ± 0.45 5.64 ± 0.19 9.95 ± 0.27
61.25 mg/kg 20.17 ± 0.61 5.29 ± 0.33 9.50 ± 0.23
125 mg/kg 22.08 ± 0.82 5.46 ± 0.22 9.24 ± 0.12 
250 mg/kg 19.57 ± 0.71 5.67 ± 0.10 9.48 ± 0.37 
500 mg/kg 20.29 ± 1.11 5.75 ± 0.24 9.94 ± 0.33 
Day 61st 
Control 19.06 ± 1.61 4.70 ± 0.32 11.05 ± 0.77
61.25 mg/kg 19.82 ± 1.75 4.32 ± 0.28 10.74 ± 0.66
125 mg/kg 20.35 ± 0.78  4.09 ± 0.14 10.63 ± 0.44
250 mg/kg 19.65 ± 1.01 4.00 ± 0.24 10.93 ± 0.36
500 mg/kg 21.12 ± 1.65 4.60 ± 0.22 10.88 ± 0.30
Day 91st 
Control 19.83 ± 0.18 3.70 ± 0.08 9.34 ± 0.71
61.25 mg/kg 19.96 ± 0.40 3.60 ± 0.06 9.35 ± 0.48
125 mg/kg 20.80 ± 0.40 4.00 ± 0.06 9.51 ± 0.66
250 mg/kg 23.79 ± 0.29* 4.77 ± 0.04* 9.32 ± 0.19
500 mg/kg 24.97 ± 0.18* 5.54 ± 0.13* 10.40 ± 0.19
Recovery
Control 18.36 ± 0.55 4.38 ± 0.54 8.05 ± 0.34
61.25 mg/kg 18.78 ± 0.38 5.15 ± 0.60 8.49 ± 0.74
125 mg/kg 18.32 ± 0.15 4.90 ± 0.42 7.74 ± 0.32
250 mg/kg 19.20 ± 0.20 5.50 ± 0.45 8.50 ± 0.51
500 mg/kg 18.61 ± 0.22 4.70 ± 0.31 9.14 ± 0.37
Values are presented as mean ± Standard error of mean (n =5). *p<0.05: Statistically significantly different from control group.
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TABLE IX - Effect of sub-chronic administration of Dryopteris filix-mas ethanol leaf extract on body weight of albino rats. 
Body weight gain (%)
31st day 61st day 91st day Recovery
Control 35.02 ± 2.00 37.97 ± 5.11 57.22 ± 2.99 48.34 ± 9.89
61.25 mg/kg 33.87 ± 1.72 38.28 ± 4.95 46.25 ± 6.41 63.57 ± 3.93
125 mg/kg 36.51 ± 2.20 51.95 ± 3.57 60.73 ± 3.48 52.44 ± 10.51
250 mg/kg 38.37 ± 3.59 42.32 ± 6.48 55.69 ± 5.35 51.81 ± 9.29
500 mg/kg 35.79 ± 2.42 47.71 ± 6.07 57.87 ± 5.84 60.53 ± 5.32
Values are presented as mean ± Standard error of mean (n =5). p>0.05: Not statistically significantly different from control group.
FIGURE 3 - 91st day kidney sections photomicrographs showing; Plate A (Control), Plate B (62.5 mg/kg), Plate C (125 mg/kg), 
Plate D (250 mg/kg), Plate E (500 mg/kg). G: Glomeruli, BS: Bowman’s space, RT: Renal tubule. GC: Glomeruli congestion. 
FIGURE 4 - Recovery kidney sections photomicrographs showing; Plate A (Control), Plate B (62.5 mg/kg), Plate C (125 mg/kg), 
Plate D (250 mg/kg), Plate E (500 mg/kg). G: Glomeruli, BS: Bowman’s space, RT: Renal tubule.
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